F. Dumont

905 total citations
29 papers, 703 citations indexed

About

F. Dumont is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience. According to data from OpenAlex, F. Dumont has authored 29 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in F. Dumont's work include Radiopharmaceutical Chemistry and Applications (9 papers), Neuroscience and Neuropharmacology Research (6 papers) and Medical Imaging Techniques and Applications (4 papers). F. Dumont is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), Neuroscience and Neuropharmacology Research (6 papers) and Medical Imaging Techniques and Applications (4 papers). F. Dumont collaborates with scholars based in Belgium, United States and Netherlands. F. Dumont's co-authors include Guido Slegers, R. A. Dierckx, Kurt Audenaert, John Mertens, K. Van Laere, C. van Heeringen, Patrick Santens, Filip De Vos, Steven C. Sutton and Christophe Van de Wiele and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Psychiatry and Journal of Controlled Release.

In The Last Decade

F. Dumont

28 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Dumont Belgium 13 174 146 145 104 103 29 703
Mark Bush United States 19 522 3.0× 193 1.3× 178 1.2× 73 0.7× 19 0.2× 59 1.4k
Melanie S. Flint United States 21 302 1.7× 82 0.6× 26 0.2× 16 0.2× 48 0.5× 56 1.2k
Erica S. Klaassen Netherlands 16 192 1.1× 116 0.8× 180 1.2× 25 0.2× 14 0.1× 52 705
Wenwen Shen China 23 655 3.8× 114 0.8× 76 0.5× 16 0.2× 38 0.4× 82 1.4k
Sajad Sahab Negah Iran 18 375 2.2× 133 0.9× 58 0.4× 35 0.3× 25 0.2× 101 1.1k
Emanuela Cazzaniga Italy 17 340 2.0× 83 0.6× 66 0.5× 14 0.1× 38 0.4× 38 812
Andrew D. Watt Australia 15 155 0.9× 70 0.5× 83 0.6× 71 0.7× 5 0.0× 23 762
Antonia Periclou United States 17 183 1.1× 125 0.9× 188 1.3× 27 0.3× 11 0.1× 36 1.2k
Yuriko Ogawa Japan 15 155 0.9× 36 0.2× 26 0.2× 14 0.1× 125 1.2× 26 815
Robert A. Lyon United States 19 566 3.3× 651 4.5× 134 0.9× 161 1.5× 7 0.1× 28 1.4k

Countries citing papers authored by F. Dumont

Since Specialization
Citations

This map shows the geographic impact of F. Dumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Dumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Dumont more than expected).

Fields of papers citing papers by F. Dumont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Dumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Dumont. The network helps show where F. Dumont may publish in the future.

Co-authorship network of co-authors of F. Dumont

This figure shows the co-authorship network connecting the top 25 collaborators of F. Dumont. A scholar is included among the top collaborators of F. Dumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Dumont. F. Dumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Callens, Chana, et al.. (2006). Influence of deposition and spray pattern of nasal powders on insulin bioavailability. International Journal of Pharmaceutics. 310(1-2). 1–7. 33 indexed citations
2.
Dumont, F., et al.. (2004). Calibration of the impedance method for rapid quantitative estimation of Escherichia coli in live marine bivalve molluscs. Journal of Applied Microbiology. 96(4). 894–902. 19 indexed citations
3.
Versijpt, Jan, K. Van Laere, R. A. Dierckx, et al.. (2003). Scintigraphic visualization of inflammation in neurodegenerative disorders. Nuclear Medicine Communications. 24(2). 209–221. 4 indexed citations
4.
Heeringen, C. van, Kurt Audenaert, K. Van Laere, et al.. (2003). Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide. Journal of Affective Disorders. 74(2). 149–158. 142 indexed citations
5.
Peremans, Kathelijne, Kurt Audenaert, Frank Coopman, et al.. (2003). REGIONAL BINDING INDEX OF THE RADIOLABELED SELECTIVE 5‐HT2A ANTAGONIST 123I‐5‐I‐R91150 IN THE NORMAL CANINE BRAIN IMAGED WITH SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY. Veterinary Radiology & Ultrasound. 44(3). 344–351. 7 indexed citations
6.
Thombre, Avinash G., et al.. (2003). Osmotic drug delivery using swellable-core technology. Journal of Controlled Release. 94(1). 75–89. 75 indexed citations
7.
Versijpt, Jan, F. Dumont, D. Decoo, et al.. (2003). Imaging of the 5-HT2A system: age-, gender-, and Alzheimer’s disease-related findings. Neurobiology of Aging. 24(4). 553–561. 81 indexed citations
8.
Staelens, Ludovicus, F. Dumont, Filip De Vos, et al.. (2003). Synthesis and radiolabelling of [123I]‐4‐iodo‐N‐(4‐(4‐(2‐methoxyphenyl)‐piperazin‐1‐yl)butyl)‐benzamide, a potential dopamine D3 antagonist for SPECT studies. Journal of Labelled Compounds and Radiopharmaceuticals. 46(5). 411–419. 2 indexed citations
9.
Staelens, Ludovicus, et al.. (2003). Synthesis and radiolabelling of [123I]‐4‐iodo‐N‐(4‐(4‐(2‐methoxyphenyl)‐piperazin‐1‐yl)butyl)‐benzamide, a potential dopamine D3 antagonist for SPECT studies. Journal of Labelled Compounds and Radiopharmaceuticals. 46(4). 297–305. 3 indexed citations
10.
Peremans, Kathelijne, Kurt Audenaert, Filip Jacobs, et al.. (2002). Biodistribution and displacement studies of the selective 5-HT2Areceptor antagonist 123I-5-I-R91150 in the normal dog. Nuclear Medicine Communications. 23(10). 1019–1027. 15 indexed citations
11.
Winter, Frédéric De, et al.. (2002). AN INFECTED HIP PROSTHESIS IN A DOG DIAGNOSED WITH A 99mTC‐CIPROFLOXACIN (INFECTON) SCAN. Veterinary Radiology & Ultrasound. 43(2). 178–182. 14 indexed citations
12.
Wiele, Christophe Van de, F. Dumont, Simon Van Belle, et al.. (2001). Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumour imaging?. Nuclear Medicine Communications. 22(1). 5–15. 38 indexed citations
13.
Vos, Filip De, F. Dumont, Kurt Audenaert, et al.. (2001). Synthesis and preliminary in vivo evaluation of 4‐[123I]iodo‐N‐{2‐[4‐(6‐trifluoromethyl‐2‐pyridinyl)‐1‐piperazinyl]ethyl}benzamide, a potential SPECT radioligand for the 5‐HT1A receptor. Journal of Labelled Compounds and Radiopharmaceuticals. 44(1). 73–88. 5 indexed citations
14.
Laere, Koen Van, Michel Koole, Kurt Audenaert, et al.. (2000). Accurate automatic fitting of brain receptor data using single-photon transmission images. European Journal of Nuclear Medicine and Molecular Imaging. 27(1). 1 indexed citations
15.
Vos, Filip De, Patrick Santens, H. Vermeirsch, et al.. (2000). Pharmacological evaluation of [11c]donepezil as tracer for visualization of acetylcholinesterase by PET. Nuclear Medicine and Biology. 27(8). 745–747. 27 indexed citations
16.
Wiele, Christophe Van de, Filip De Vos, Johan De Sutter, et al.. (1999). Biodistribution and dosimetry of (iodine-123)-iodomethyl- N , N -diethyltamoxifen, an (anti)oestrogen receptor radioligand. European Journal of Nuclear Medicine and Molecular Imaging. 26(10). 1259–1264. 7 indexed citations
17.
Dumont, F. & Guido Slegers. (1997). Synthesis and in vivo evaluation of 7-chloro-5-[123I]iodo-4-oxo-1,4-dihydroquinoline-2-carboxylic acid. Applied Radiation and Isotopes. 48(9). 1173–1177. 6 indexed citations
18.
Dumont, F., et al.. (1997). Radiolabelling optimisation of 7-bromo-5-[123I]-iodo-4-oxo-1,4-dihidroquinoline-2-carboxylic acid: a potential tracer for NMDA SPECT studies. Journal of Radioanalytical and Nuclear Chemistry. 218(2). 239–241.
19.
Dumont, F., et al.. (1996). Synthesis of [77Br] 5,7-dibromo-4-oxo-1,4-dihydroquinoline-2-carboxylic acid, a possible SPECT tracer for NMDA receptor studies. Journal of Labelled Compounds and Radiopharmaceuticals. 38(9). 795–802. 2 indexed citations
20.
Schittecatte, Michel, G Charles, F. Dumont, et al.. (1994). Effects of gender and diagnosis on growth hormone response to clonidine for major depression: a large-scale multicenter study. American Journal of Psychiatry. 151(2). 216–220. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026